Desq Long
Sign in

Company

Aquestive Therapeutics, Inc.

AQST · CIK 0001398733

SEC FORM 4
$120,487.50

Aquestive Therapeutics, Inc. (AQST)

Sale of 25,000 shares at $4.8195 per share.

Reporting Person Barber Daniel · Officer Title President and CEO · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001214659-26-011731 · filed 2026-09-16 · View filing →

SEC FORM 4
$23,187.50

Aquestive Therapeutics, Inc. (AQST)

Acquisition (code M) of 8,750 shares at $2.65 per share.

Reporting Person Korczynski Sherry · Officer Title Chief Commercial Officer · Transaction Code M

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001214659-26-011596 · filed 2026-09-11 · View filing →

SEC FORM 4
$45,675.00

Aquestive Therapeutics, Inc. (AQST)

Sale of 8,750 shares at $5.22 per share.

Reporting Person Korczynski Sherry · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001214659-26-011596 · filed 2026-09-11 · View filing →

SEC FORM 4
$2,201.28

Aquestive Therapeutics, Inc. (AQST)

Acquisition (code X) of 2,293 shares at $0.96 per share.

Reporting Person Boyd Peter E. · Officer Title Chief People Officer · Transaction Code X

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001214659-26-011541 · filed 2026-09-10 · View filing →

SEC FORM 4
$88,073.28

Aquestive Therapeutics, Inc. (AQST)

Acquisition (code X) of 91,743 shares at $0.96 per share.

Reporting Person Barber Daniel · Officer Title President and CEO · Transaction Code X

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001214659-26-011539 · filed 2026-09-09 · View filing →

SEC FORM 4
$4,403.52

Aquestive Therapeutics, Inc. (AQST)

Acquisition (code X) of 4,587 shares at $0.96 per share.

Reporting Person Jung Cassie · Officer Title Chief Operating Officer · Transaction Code X

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001214659-26-011475 · filed 2026-09-08 · View filing →

SEC FORM 4
$107,167.50

Aquestive Therapeutics, Inc. (AQST)

Sale of 25,000 shares at $4.2867 per share.

Reporting Person Barber Daniel · Officer Title President and CEO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001214659-26-010516 · filed 2026-08-18 · View filing →

SEC FORM 4
$11,534.50

Aquestive Therapeutics, Inc. (AQST)

Disposition (code F) of 2,714 shares at $4.25 per share.

Reporting Person Korczynski Sherry · Officer Title Chief Commercial Officer · Transaction Code F

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001214659-26-010474 · filed 2026-08-17 · View filing →